Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia

Federation, 2013 Standards of medical care in diabetes-2012. Diabetes Care 35 (Suppl. 1) (2012) S11–S63. Handelsman, 2011, American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan, Endocrine Practice, 17, 1, 10.4158/EP.17.S2.1 Turner, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Steinberg, 2008, Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease, American Heart Journal, 156, 719, 10.1016/j.ahj.2008.05.020 Dodd, 2009, Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004, Current Medical Research and Opinion, 25, 1605, 10.1185/03007990902973300 Tong, 2008, Use of anti-diabetic drugs and glycaemic control in type 2 diabetes—The Hong Kong Diabetes Registry, Diabetes Research and Clinical Practice, 82, 346, 10.1016/j.diabres.2008.09.006 Toh, 2007, Measuring the quality of care of diabetic patients at the specialist outpatient clinics in public hospitals in Singapore, Annals-Academy of Medicine Singapore, 36, 980, 10.47102/annals-acadmedsg.V36N12p980 Wong, 2011, Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore, Diabetic Medicine, 28, 206, 10.1111/j.1464-5491.2010.03195.x Wright, 2002, Sulfonylurea Inadequacy Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57), Diabetes Care, 25, 330, 10.2337/diacare.25.2.330 Peyrot, 2005, Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care, 28, 2673, 10.2337/diacare.28.11.2673 Edelman, 2014, Challenges associated with insulin therapy in type 2 diabetes mellitus, The American Journal of Medicine, 127, S11, 10.1016/j.amjmed.2014.07.003 Wild, 2012, The economic rationale for adherence in the treatment of type 2 diabetes mellitus, The American Journal of Managed Care, 18, S43 Wens, 2005, GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: a qualitative analysis of barriers and solutions, BMC Family Practice, 6, 20, 10.1186/1471-2296-6-20 Vinter-Repalust, 2004, Obstacles which patients with type 2 diabetes meet while adhering to the therapeutic regimen in everyday life: qualitative study, Croatian Medical Journal, 45, 630 Tan, 2003, RETHINK: an observational cross sectional study on the uptake of insulin therapy among type 2 diabetes patients with secondary drug failure treated in primary care patients with secondary drug failure treated in primary care, Asia Pacific Family Medicine, 2, 157, 10.1046/j.1444-1683.2003.00074.x Jeavons, 2006, Patients with poorly controlled diabetes in primary care: healthcare clinicians’ beliefs and attitudes, Postgraduate Medical Journal, 82, 347, 10.1136/pgmj.2005.039545 Brod, 2009, Psychological insulin resistance: patient beliefs and implications for diabetes management, Quality of Life Research, 18, 23, 10.1007/s11136-008-9419-1 Polonsky, 2007, Psychological insulin resistance: the patient perspective, The Diabetes Educator, 33, 241S, 10.1177/0145721707305701 Polonsky, 2005, Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem, Diabetes Care, 28, 2543, 10.2337/diacare.28.10.2543 Larkin, 2008, Measuring psychological insulin resistance barriers to insulin use, The Diabetes Educator, 34, 511, 10.1177/0145721708317869 Khan, 2008, Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London, Diabetic Medicine, 25, 1108, 10.1111/j.1464-5491.2008.02538.x Tan, 2015, Insulin therapy refusal among type II diabetes mellitus patients in Kubang Pasu district, Kedah, Malaysia, Singapore Medical Journal, 56, 224, 10.11622/smedj.2014170 Ghadiri-Anari, 2013, Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus, Acta Medica Iranica, 51 Polonsky, 2004, What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes, Clinical Diabetes, 22, 147, 10.2337/diaclin.22.3.147 Hassan, 2013, Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration, BMC Family Practice, 14, 164, 10.1186/1471-2296-14-164 Al-Saeedi, 2002, Treatment-related misconceptions among diabetic patients in Western Saudi Arabia, Saudi Medical Journal, 23, 1243 Al-Khaldi, 2000, Audit of a diabetic health education program at a large Primary Health Care Center in Asir region, Saudi Medical Journal, 21, 838 Al-Maatouq, 2010, Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin, International Journal of Clinical Practice, 64, 149, 10.1111/j.1742-1241.2009.02235.x Gherman, 2011, Psychological insulin resistance: a critical review of the literature, Practical Diabetes International, 28, 125, 10.1002/pdi.1574 Zainuddin, 2011, Psychological insulin resistance (PIR) among type 2 diabetes patients at public health clinics in federal territory of Malaysia, The International Medical Journal of Malaysia, 10 Alsunni, 2014, Determinants of misconceptions about diabetes among Saudi diabetic patients attending diabetes clinic at a tertiary care hospital in Eastern Saudi Arabia, Journal of Family & Community Medicine, 21, 93, 10.4103/2230-8229.134764 Al-Rasheedi, 2015, Glycemic control among patients with type 2 diabetes mellitus in countries of Arabic Gulf, International Journal of Health Sciences, 9, 345, 10.12816/0024701 Brod, 2014, Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities, The Patient-Patient-Centered Outcomes Research, 7, 437, 10.1007/s40271-014-0068-x Peyrot, 2010, Addressing barriers to initiation of insulin in patients with type 2 diabetes, Primary Care Diabetes, 4, S11, 10.1016/S1751-9918(10)60004-6 Marrero, 2008, Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus, Clinical Cornerstone, 9, 63, 10.1016/S1098-3597(09)62041-X Meece, 2006, Dispelling myths and removing barriers about insulin in type 2 diabetes, The Diabetes Educator, 32, 9S, 10.1177/0145721705285638 Funnell, 2007, Overcoming barriers to the initiation of insulin therapy, Clinical Diabetes, 25, 36, 10.2337/diaclin.25.1.36 Snoek, 2007, Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes, Health and Quality of Life Outcomes, 5, 69, 10.1186/1477-7525-5-69 Casciano, 2011, A quantitative assessment of patient barriers to insulin, International Journal of Clinical Practice, 65, 408, 10.1111/j.1742-1241.2010.02590.x